arrow
S

Stefano Aliberti

institut d'investigacio biomedica de bellvitge (idibell)
H指数:80
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lpb. plantarum inhalation powders for the reduction of lung inflammation and S. aureus growth control in non-CF bronchiectasis

植物乳杆菌吸入粉剂用于减少非囊性纤维化支气管扩张症的肺炎症和金黄色葡萄球菌生长控制

2026-09-080
PRE
Managing the Overlap: Bronchiectasis and Inflammatory Bowel Disease in the Era of Precision Medicine

管理重叠:支氣管擴張症與炎症性腸病在精準醫學時代的關係

2026-05-070
PRE
Biophysical and aerodynamic properties of a peptide targeting the A-kinase anchoring function of PI3Kγ for pulmonary cAMP modulation

靶向PI3Kγ的A-激酶锚定功能的肽段在肺泡cAMP调控中的生物物理和空气动力学特性

2026-04-200
OAAI
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study

AI生成答案的准确性、全面性和易懂性:针对COPD患者问题的AIR-COPD研究

2025-12-160
OAAI
Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis

烟曲霉致敏与高风险支气管扩张相关

CHEST
IF8.6
2025-12-110
PREAI
Community pharmacies in early detection of obstructive sleep apnea: findings from a nationwide survey

社区药房在阻塞性睡眠呼吸暂停早期检测中的作用:全国调查结果

2025-11-280
OAAI
A machine learning model including pentraxin-3 as predictor of outcomes in community-acquired pneumonia

一种将血清淀粉样蛋白A3(pentraxin-3)作为预测指标,用于社区获得性肺炎结局预测的机器学习模型。

2025-11-020
OAAI
Systemic immune dysregulation in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection

支气管扩张合并慢性铜绿假单胞菌感染患者的系统性免疫失调

2025-10-250
PRE
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

症状、未来急性加重的风险以及对长期大环内酯治疗的反应:一项观察性研究

2025-08-270
OAAI
Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study

免疫抑制患者中的医院获得性下呼吸道感染:一项队列研究

2025-05-060
OA